Dr Reddys Laboratories (RDY) Enterprise Value Growth (1y) (2010 - 2026)
Dr Reddys Laboratories (RDY) Enterprise Value Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.31 Bn | 39.66 Bn | 2.15 Bn |
| 3 | Zoetis | 31.65 Bn | 29.98 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.18 Bn | 19.52 Bn | 683.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.94 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.70 Bn | 15.31 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.26% |
| Mar 31, 2025 | -105.75% |
| Mar 31, 2024 | 85.78% |
| Jun 30, 2023 | -351.91% |
| Mar 31, 2023 | -4.62% |
| Mar 31, 2022 | -165.91% |
| Mar 31, 2021 | 35.48% |
| Dec 31, 2020 | 80.36% |
| Sep 30, 2020 | 26.67% |
| Mar 31, 2020 | -821.62% |
| Dec 31, 2019 | -121.96% |
| Mar 31, 2019 | -109.37% |
| Dec 31, 2018 | 100.00% |
| Jun 30, 2018 | -30.35% |
| Mar 31, 2018 | -48.09% |
| Dec 31, 2017 | -15.82% |
| Sep 30, 2017 | 16.51% |
| Jun 17, 2017 | 338.76% |
| Dec 31, 2016 | -464,062,400.00% |
| Sep 30, 2016 | -684,782,708.69% |